Reinnervate is pleased to announce that Professor Stefan Przyborski, Reinnervate’s founder and Chief Scientific Officer, will be presenting at the third annual conference on Cell-based Assays on 22-23 November at the Marriott Regent Park, London.
Professor Przyborski’s presentation, at 9.45am on Tuesday, 23 November, will be on the development and use of the of the company’s core Alvetex® technology platform for routine 3D cell culture. The talk will also describe how Alvetex has been applied to bone, liver, skin and stem cells for modelling disease, toxicity screening and drug safety testing.
The Cell-based Assays conference brings together some of the world’s leading companies developing cell-based technologies to discuss the latest techniques, technologies and methods used in cell-based assays. These technologies have been progressing at breakneck speed and Professor Przyborski is delighted to be included in the list of leading experts from both industry and academia able to present the latest technological advances.
More information about the conference can be found here